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CEA and CEACAM6 are immunoglobulin family intercellular adhesion molecules that are up-regulated without structural
mutations in approximately 70% of human cancers. Results in in vitro systems showing tumorigenic effects for these molecules
suggest that this correlation could indicate an instrumental role in tumorigenesis. To test whether this applies in vivo,
transgenic mice harboring 187 kb of the human genome containing four CEA family member genes including the CEA and
CEACAM6 genes were created and their copy numbers increased by mating until colonocyte expression levels reached levels
seen in human colorectal carcinomas. The colonocyte surface level of integrin a5 and the activation of AKT increased
progressively with the expression levels of CEA/CEACAM6. Colonic crypts showed a progressive increase in colonocyte
proliferation, an increase in crypt fission, and a strong inhibition of both differentiation and anoikis/apoptosis. All transgenic
mice showed massively enlarged colons comprising a continuous mosaic of severe hyperplasia, dysplasia and serrated
adenomatous morphology. These results suggest that up-regulated non-mutated adhesion molecules could have a significant
instrumental role in human cancer.
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INTRODUCTION
The human CEA family of cell surface intercellular adhesion
molecules, a sub-family of the Immunoglobulin Superfamily,
consists of both glyco-phosphatidylinositol (GPI) and transmem-
brane (TM) anchored members [1]. GPI-anchored members,
CEA and CEACAM6, show up-regulation in 50–70% of all
human cancers, including colon, breast and lung cancers [1–4]. In
fact, CEA represents a major tumor marker used widely in the
management of colorectal cancer [5–7]. The TM-anchored
member, CEACAM1, on the other hand, usually shows down-
regulation in cancers [1]. The question arises as to whether or not
the positive correlation between CEA/CEACAM6 levels and
tumors points to an instrumental role for these molecules in
cancer. This question has significance for the clinical interpreta-
tion of CEA and CEACAM6 levels in tumors and for the
development of CEA-targeted therapies. In spite of the fact that
CEA and CEACAM6 are normally up-regulated as differentiation
proceeds during the movement of colonocytes up colonic crypts
[4,8], experiments with various model systems in vitro, including
cultured human colorectal carcinoma colonocytes, have shown
that if CEA and/or CEACAM6 are inappropriately up-regulated
in cells with division potential prior to differentiation, differentia-
tion is blocked [9–11], cell polarization and tissue architecture are
disrupted [10] and anoikis/apoptosis is inhibited [12–15]. All of
the above effects can contribute to tumorigenicity and, in fact,
ectopic expression in rat L6 myoblasts [16] or over-expression in
human Caco2 colonocytes [10] of CEA and/or CEACAM6 prior
to differentiation leads to a marked decrease in the latent period
for tumor formation in nude mice.
The molecular mechanism for the observed tumorigenic effects
of CEA and CEACAM6 could provide insight in considering this
question. The structural requirements for CEA’s differentiation-
blocking ability have been shown to be self-associating external
domains linked to a CEA-specific GPI anchor [17], the former to
effect clustering and the latter to provide activation specificity
following clustering [18,19]. CEA occupies membrane micro-
domains (membrane rafts), which tend to cluster as the CEA cell
surface density increases as it does in many cancers (see above).
CEA external domain mutants deficient in self-binding have no
effect on differentiation but become effective immediately after
antibody-mediated cross-linking [18]. Thus, within 5 minutes after
cross-linking, integrin a5b1, a cell surface heterodimeric receptor
affecting cell-extracellular matrix/cell-cell interactions involved in
cell proliferation, differentiation and survival [20], becomes
activated and co-localizes with CEA in larger membrane
structures; rapid localization in low density membrane micro-
domains of ILK, AKT and MAPK and phosphorylation of AKT
and MAPK are also observed [21], presumably because all of
these elements occupy the same membrane rafts as CEA.
Similarly, antibody-mediated cross-linking of CEACAM6 activates
integrin avb3 in a pancreatic cancer cell line [22]. Integrin
activation and subsequent activation of the PI3K/AKT and
MAPK pathways have been reported by other groups to have the
same effects observed here on differentiation and anoikis [23–25].
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CEA and CEACAM6 in tumorigenesis.
The above results utilized various in vitro model systems
involving CEA/CEACAM6 transfectants and could therefore
have given findings that do not apply in vivo. To address this
important caveat and to examine effects on tissue architecture in a
valid setting, it was decided to construct transgenic mice
containing human genes for CEA and CEACAM6. Mice do not
possess GPI-anchored CEA family members, having only analogs
of human TM-anchored CEACAM1 [26], making this experi-
ment appropriate. Previous transgenics harboring the human CEA
gene only, while showing the same pattern of tissue specific
expression as in humans [27,28], did not show a predilection for
developing more tumors even when crossed with tumor susceptible
mutant mice, such as APC
Min/+ mice [29]. These mice, however,
lacked CEACAM6 that is usually co-overexpressed with CEA in
cancers, had transgene expression levels that could have been
below those observed in human tumors and lacked upstream and
downstream genomic sequences in their transgenes that could
have been necessary for derangement of their expression, e.g., in
colonocytes with division potential.
The above deficiencies were dealt with by creating transgenic
mice containing a 187 kb insert from a bacterial artificial
chromosome (BAC) that included the complete human genes for
CEA, CEACAM6, CEACAM7 and CEACAM3 plus about 20–
30 kb of both upstream and downstream sequences [30]. The
expression patterns of these genes were almost identical to human
patterns, showing normal expression of CEA and CEACAM6 in
colorectal crypts with, unlike the CEA-only transgenics by Eades-
Perner et al., the correct gradient, i.e., higher towards the upper
ends of the crypts. They also showed very low colorectal cryptal
expression of CEACAM7 and no colorectal expression of
CEACAM3 [30]. Two independent transgenic founders were
obtained with 2 and 10 head-to-tail copies of the transgene and
colonic expression levels directly proportional to their copy
number [30]. Higher copy transgenics were then derived by
mating the 10 copy founders to give 20 copy homozygotes and a
further 2-fold increase in colonic expression. The latter expression
levels were in the range observed in human colorectal carcinomas.
We were thus poised to look for possible tumorigenic effects of
CEA and CEACAM6 in an in vivo system that more closely
approximated the human situation.
These transgenic mice showed dramatic expression level-
dependent tumorigenic effects: with some variation in detail, the
same changes in integrin a5b1, ILK and AKT as seen in the in vitro
model systems were observed in purified colonocytes; furthermore,
the mice showed inhibition of colonocyte differentiation (at least
for the goblet cell lineage) and anoikis and disruption of tissue
architecture characteristic of extreme hyperplasia and dysplasia.
RESULTS
Construction of CEABAC Transgenic Mice
CEABAC2 and CEABAC10 transgenic mice are independent
founders containing 2 and 10 head-to-tail copies, respectively, of
the 187 kb genomic DNA insert of a BAC which includes the
genes for human CEA, CEACAM6, CEACAM7 and CEACAM3
[30]. The tissue specific expression patterns for these genes have
been documented previously [30] and are almost identical to those
in humans [1]. CEABAC20 mice with 20 copies were obtained by
mating CEABAC10 mice, which are heterozygous for the
transgene. In situ hybridization with a fluorescein isothiocyanate
(FITC)-labeled CEA cDNA probe of cell nuclei showed a single
spot for CEABAC10 and two spots for CEABAC20 (Figure 1A),
which is consistent with the previous molecular analysis of
CEABAC10 indicating head-to-tail linkage of all copies into one
complex [30]. The CEABAC20 mice could be immediately
recognized in litters because of their significantly smaller size
(Figure 1B), which could be attributed to impaired gastrointestinal
function (see below).
Immunoblot analysis for CEA and CEACAM6 expression in
the colons of 3 month old mice is shown in Figure 1C. As
expected, wild-type (WT) mice show no expression of these human
CEACAM family members, whereas CEABAC2, CEABAC10
and CEABAC20 mice show increasing expression levels in direct
proportion to their transgene copy number.
The spatial expression pattern, both qualitatively and quantita-
tively, was important to assess, if any of these mice were to serve as
models for human colorectal carcinogenesis. Appropriately elevated
expression levels in colonocytes in the proliferative zone of colonic
crypts would be required for this. As an approximate estimate,
immunohistochemistry for CEA/CEACAM6 was performed on
colonic sections from 3 week and 3 month old transgenic mice and
compared with that of human colorectal carcinomas at a common
stage of progression. In concordance with the immunoblot analysis,
CEABAC2, CEABAC10 and CEABAC20 mice showed increasing
expression levels of CEA/CEACAM6 in the transgenic colons at
3 weeks of age (Figure 1D). However, the high expression level of
CEA/CEACAM6 in the CEABAC20 mice was no longer restricted
to the apical surface. Moreover, intracellular localization of CEA/
CEACAM6 was more evident in the CEABAC20 mice (Figure 1D).
By 3 months of age, the expression level and pattern of CEA/
CEACAM6 in the CEABAC20 miceweresimilar to thoseof human
colorectal carcinomas (Figure 1E).
Molecular Changes in CEABAC Colonocytes
A case for a positive change in the activation state of integrin a5b1
as a result of CEA clustering was made from previous in vitro
studies (see Introduction). Here, using purified colonocytes from
the transgenic mice, it was not technically possible to measure
their binding to fibronectin, the major ligand of integrin a5b1, as
an indication of its activation state. However, the cell surface level
of integrin a5 was higher in CEABAC2 than in WT colonocytes
and even higher in CEABAC10 (Figure 2C). This finding
correlated well with the cell surface levels of CEA and CEACAM6
in the CEABAC2 and CEABAC10 mice (Figures 2A and 2B).
CEABAC20 colonocytes were not included in this part of the
characterization because the extensive distortion of the crypt
architecture (see below) rendered their isolation too difficult using
the current method. The expression level of integrin a2 showed no
such increase with CEA/CEACAM6 expression (Figure 2D) and
integrin av could not be detected (data not shown). These results
suggest that integrin a5b1 signaling could be increased in
colonocytes from CEABAC transgenic mice and in a CEA/
CEACAM6 gene dose-dependent fashion.
In agreement with the latter supposition, a shift in subcellular
localization towards less dense membrane complexes typical of
membrane rafts for integrin a5, ILK and AKT and an increase in
phosphorylation for AKT were observed in purified colonocytes
from CEABAC2 and CEABAC10 mice relative to WT littermate
mice (Figure 3A & C), as was previously seen for these elements in
various in vitro systems [21]. No such changes were observed for the
integrin a2 subunit, the integrin b1 subunit or FAK (Figure 3A).
However, since the overall detection level of integrin b1 (in contrast
to integrin a2 and FAK) was very low and no visible signal was
detected in the low-density membrane fractions, the failure to see a
shiftinthesubcellularlocalizationofintegrinb1wasquestionable.In
addition, the b1 subunit is shared by many a subunits and so might
Tumorigenesis in Ceabac Mice
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undetectable in this experiment (data not shown).
These increases were understandably less dramatic than those
observed in vitro in which the events were synchronized by cross-
linking cell surface mutant CEA molecules that lacked self-adhesive
external domains [21]. Here, antibody-mediated cross-linking of
CEA and CEACAM6 in the purified colonocytes accentuated the
shift of ILK towards less dense membrane complexes (Figure 3B),
which is consistent with the suggestion that they arose as a
consequence of CEA/CEACAM6 clustering leading to integrin
a5b1 activation. Regardless of the verity of the latter interpretation,
the results provide evidence for the activation of AKT, an
acknowledged consequence of integrin activation [20,25].
Cellular Changes in CEABAC Colonocytes
What are the cellular consequences in vivo of the increase in cell
surface density of integrin a5 and the consequent downstream
molecular activation events that arise from the presence of the
CEABAC transgenes in colonocytes? A transgene copy number-
dependent increase in the colonocyte proliferation index indicated
by PCNA staining was observed in colonic crypts from 3 week-old
CEABAC transgenics relative to WT littermates (Figure 4B). This
was due to the progressive extension (with CEABAC dose) of the
proliferative zone towards the upper parts of the crypts reaching the
full length of the crypts in CEABAC20 mice (Figure 4A). This effect
resulted inan overallincrease inthe length oftheCEABAC20crypts
(Figures 4A and 5A). There was also a marked CEABAC dose-
dependent increase in the incidence of crypt fission (Figure 4C), the
process whereby new crypts are created in the colon [31].
Lastly, a strong CEABAC dose-dependent decrease in the
differentiation of colonocytes, at least for the goblet cell lineage in
the crypts, was observed in the transgenic mice (Figure 5),
consistent with the pan-inhibition of cellular differentiation noted
in various in vitro systems [9–11].
Hyperplastic and Dysplastic Changes in CEABAC
Colons
A progressive shift with CEABAC dose towards a deranged tissue
architecture featuring more mucosal tissue and less luminal space
was seen in cross sections of colons from 3 week-old transgenic
mice (Figure 4D). This effect became quite dramatic in
CEABAC20 mice by 3 months of age, where 100% of the mice
showed grossly enlarged colons with crypts up to 10 times normal
length and with virtually no central lumen (Figure 6). These mice
were considerably smaller than normal (Figure 1B), had persistent
Figure 1. Expression of CEA and CEACAM6 in the CEABAC mouse colon. A) Images of fluorescence in situ hybridization (FITC-labeled CEA cDNA
probes and DAPI-stained nuclei) show one nuclear spot (red arrow) for CEABAC10 and two for CEABAC20. Magnification: 10006. B) Significant
reduction visually of body size of CEABAC20 mice at 3 weeks of age. C) Immunoblots of colon protein extracts show a correlation between expression
levels of CEA (detected with A20 mAb) and CEACAM6 (detected with 9A6 mAb) and CEABAC transgene copy numbers in the CEABAC mice
(CEABAC2, CEABAC10 and CEABAC20). D) Immunohistochemical staining (brown staining) for human CEACAM (detected with RbaCEA) in 3 week-old
mouse colons shows increasing expression levels of CEA/CEACAM6 correlated with the transgene copy number. The high expression level of CEA/
CEACAM6 in the CEABAC20 mice was no longer restricted to the apical surface (red arrow points to apical surface staining; black arrows point to
basolateral staining) and significant intracellular localization of CEA/CEACAM6 was also evident. E) Immunohistochemical staining (brown staining)
for human CEACAM (detected with RbaCEA) in 3 month-old CEABAC20 mouse colons shows levels and patterns of CEA/CEACAM6 expression which
are similar to those of human colorectal carcinomas at a similar stage of progression. WT denotes wild-type littermate.
doi:10.1371/journal.pone.0001353.g001
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weeks of life to about 9 months maximum; all animals died with
rectal prolapse. The effects were more pronounced in female,
especially pregnant, mice than in males.
Histological analysis of colonic mucosa from the 3 month-old
CEABAC20 mice showed a non-focal continuous mosaic of severe
hyperplasia, crypt serration and dysplasia (Figure 7). Dysplastic
features included colonocyte stratification, displaced nuclei with
prominent nucleoli and loss of polarization.
A further change, characteristic of neoplasia, was the inhibition
of anoikis, the apoptotic process that normally removes cells that
are not properly anchored to the extra-cellular membrane and
which therefore acts as a quality control mechanism for tissue
architecture [24]. If the CEA/CEACAM6-mediated disruption of
tissue architecture is to persist, this process needs to be inhibited.
In fact, crypts from 3 month-old CEABAC20 mice often showed
CEA/CEACAM6-positive anchorless cells in their lumens that
were negative for staining by the TUNEL assay; such cells were
not seen in WT crypts (Figure 8A). Moreover, protein extracts
from CEABAC20 colonic mucosa showed less PARP cleavage
than from WT mucosa (Figure 8B), suggesting that the proportion
of cells undergoing apoptosis was less in the CEABAC20 mice
than in WT mice. In addition, colonocytes purified from isolated
crypts of even the reduced CEABAC dose CEABAC2 and
CEABAC10 mice, when maintained in suspension, showed a
dramatic reduction in apoptosis (Figures 8C and 8D). At the
molecular level, the cleavage of caspase-3, which represents a
hallmark of apoptosis [32], was also reduced in the suspended
CEABAC2 and CEABAC10 colonocytes (Figure 8E).
DISCUSSION
The fact that CEA and/or CEACAM6 are over-expressed in so
many human cancers has led us and others to suggest that this
effect could contribute to tumorigenesis [4,10,12,33]. However,
the normally elevated expression of these molecules in differen-
tiated epithelial cells presents a conundrum. Although evidence for
tumorigenic effects of CEA and CEACAM6 has been documented
in many diverse systems in vitro (see Introduction), the latter could
be criticized for being model systems that fail to represent the real
situation in vivo. This study, however, utilizing transgenic mice
Figure 2. Cell surface expression of CEACAM and integrins on purified colonocytes. FACS profiles of WT (shaded area), CEABAC2 (dotted line) and
CEABAC10 (solid line) purified colonocytes. A–B) FACS profiles of CEA detected by T84.66 mAb (A) and CEACAM6 detected by 9A6 mAb (B), show a
higher cell surface expression of CEA and CEACAM6 in the CEABAC10 than CEABAC2 colonocytes, whereas wild-type (WT) colonocytes show only a
background flurorescence. C) FACS profiles of integrin a5 detected by HMa5-1 mAb show increasing cell surface expression levels of integrin a5 with
increasing CEA/CEACAM6 cell surface expression levels (A–B). D) FACS profiles of integrin a2 detected by HMalpha2 mAb show the same cell surface
or even less expression levels of integrins a2.
doi:10.1371/journal.pone.0001353.g002
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tissue specific pattern but with increasing expression levels to the
point of those found in human carcinomas, represents perhaps the
closest approximation to the human situation yet investigated. The
results were striking in that purified colonocytes from these mice
showed CEA/CEACAM6 expression level-dependent molecular
changes involving integrin activation similar to those documented
in the in vitro systems; tumorigenic cellular changes were observed
such as increased proliferation and inhibition of differentiation and
anoikis/apoptosis; and, finally, these cellular changes were
mirrored by dramatic changes in colonic tissue architecture
featuring severe hyperplasia and dysplasia, to the point of
rendering the entire colon a massive tumor-like structure. The
resolution of the above conundrum is suggested to be that elevated
expression of CEA/CEACAM6 in colonocytes prior to their
differentiation and loss of division potential is required for the
manifestation of their tumorigenic effects.
Molecular Basis of Tumorigenic Changes
We suggest that the initial molecular events involved in these effects
consist of CEA/CEACAM6-mediated clustering of membrane
microdomains that specifically contain these adhesion molecules,
integrin a5b1, and a limited repertoire of cytoplasmic signaling
elements, including ILK, PI3K and AKT. The co-clustering causes
integrin a5b1 to become activated, along with the PI3K/AKT
pathway, by successive waves of inside-out and outside-in signaling
[34,35] resulting in inhibition of cell differentiation and anoikis and
stimulation of cell proliferation–the latter previously documented
by other groups to be caused by integrin activation [36,37];
ultimately, tissue architecture is profoundly perturbed. Much of the
evidence for this suggested model comes from detailed studies of
the more experimentally amenable in vitro systems [19,21,22,38]
and the fact that these are mirrored by key changes in purified
colonocytes from the CEABAC transgenics implies that it could
apply in this situation too.
The question arises as to whether these effects could have been
due to a random insertional mutation of an endogenous gene
rather than to direct effects of the elevated expression levels of
CEA and CEACAM6. The former is unlikely, however, for the
following reasons. First, random mutation of endogenous genes by
transgenesis is an uncommon event [39]. Secondly, the probability
of mutation of a gene resulting in an anticipated effect, i.e.,
specifically colorectal tumorigenesis, is even lower. Thirdly, to our
knowledge, such dramatic tumorigenic effects have never been
reported in any knockout models. Lastly and most importantly,
both independently produced transgenic lines (CEABAC2 and
CEABAC10), which would have different sites of integration,
showed similar tumorigenic changes directly related quantitatively
to expression level.
It is not clear from this work, however, which of the CEACAMs
present in the CEABAC are responsible for these effects. Since, as in
humans, CEACAM7 is expressed only at very low levels in these
transgenics’ colons [30] and is under-expressed rather than over-
expressed in human colorectal cancers [1], and CEACAM3 is not at
all expressed in the colon [1,30], it seems very likely that CEA and/
or CEACAM6 are responsible and, in fact, both of the latter genes
have been shown to elicit tumorigenic effects in various model
systems in vitro and in xenograft mouse models [9–15,40]. It is
possible that over-expression of both CEA and CEACAM6 are
required for these effects in vivo, which would explain the failure to
see them in CEA-only transgenics [27–29], although it is equally
Figure 3. Subcellular localization of CEACAM and integrin signaling elements in purified colonocytes. A) Immunoblots of different membrane
fractions of purified colonocytes derived from sucrose density gradients show a shift in subcellular localization from high density (H) towards low
density (L) membrane complexes for integrin a5, ILK, total AKT and Ser473-phosphorylated AKT (pAKT) in purified colonocytes from CEABAC2 and
CEABAC10 mice relative to WT littermate mice. No such shift was observed for integrin a2, integrin b1 and FAK. GM1 is a marker for membrane raft-
containing membrane fractions. Note that these immunoblots are representative of three independent experiments using at least 6 mice per mouse
group. B) Antibody-mediated cross-linking of CEA and CEACAM6 with J22 mAb in the purified colonocytes accentuates the shift of ILK to the less
dense membrane fractions shown in A. C) Densitometric analysis of immunoblots for AKT and pAKT shown in A. The mean densitometric ratios (the
intensity of band in L divided by the one in H) from three independent experiments show a statistical significant shift of AKT and pAKT to the low
density membrane complexes in the CEABAC colonocytes (P,0.001 for AKT and P,0.005 for pAKT). Error bars = SEM (N=3).
doi:10.1371/journal.pone.0001353.g003
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too low or that the CEACAM6 expression is the key determinant.
With the likely assumption that the effects are due to CEA and
CEACAM6, clustering of these molecules as their concentration
increases by self-binding of their adhesive external domains [18] is
suggested to be the initial event leading to the changes in cellular
state observed here. This suggestion is supported by previous work
with several cell lines expressing a CEA mutant that is defective in
self-binding. None of the molecular events, including integrin
a5b1 activation, or the cellular events, including inhibition of
differentiation were produced by this mutant, but all these events
were promptly restored by cross-linking with specific antibodies
[18,21]. In this study, the tumorigenic effects were strongly gene
dose dependent, which would be expected if they depended on
self-binding and clustering, which would be a positive power
function (at least a square function) of cell surface molecular
concentration. This was most apparent in the case of the
disruption of colonic tissue architecture, which was extreme in
the case of the CEABAC20 mice. It is of interest that the
CEABAC2 and CEABAC10 mice, which showed more moderate
colonic changes, were nevertheless much more prone to produce
carcinogen-induced focal colorectal tumors than WT mice [41].
Evidence for the involvement of integrin a5b1 activation,
previously shown in in vitro systems, was obtained in the
observation of a CEABAC dose-dependent increase in the
colonocyte surface concentration of this integrin relative to WT
Figure 4. Hyperproliferation in CEABAC mouse colonic epithelium at 3 weeks of age. A) Extension of the proliferative zones in colonic crypts is
shown for both CEABAC10 and CEABAC20 by PCNA staining. Lengthening of crypts, poor cryptal alignment, increase of peri-cryptal stroma, and
elongation of nuclei are noted in CEABAC20 mice, indicating hyperplastic changes. Arrow shows an example of crypt fission used to calculate percent
crypt fission for C. B) Proliferation indices estimated by PCNA staining in A show significant increases for both CEABAC10 and CEABAC20 from WT
mice (P,0.0001). C) Percent crypt fission plotted against transgene copy-number shows a linear curve with a correlation coefficient of 0.977; each
data point is significantly different from the others (P,0.0001). D) Cross sections of colons show increasing epithelial content with increasing CEABAC
transgene copy number (i.e. CEA/CEACAM6 expression levels). Magnification: 4006(A), 1006(D). Staining: hematoxylin. Error bars represent standard
errors of the mean (N=9). WT denotes wild-type littermate.
doi:10.1371/journal.pone.0001353.g004
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that this increase is due to an initial activation of integrin a5b1, as
observed in vitro, followed by an increase in cell surface level, a
positive feedback control loop previously documented for integrins
in many other systems [42,43]. If so, it could imply that the
colonocyte integrin a5b1 molecules are not only increased in
number but also in activation state, although this would obviously
require direct confirmation. The CEABAC mouse colonocytes
showed evidence for the activation of AKT but, in preliminary
experiments, no evidence for activation of the Wnt-signaling
pathway could be demonstrated, in that no nuclear accumulation
of b-catenin was seen (Chan and Stanners, unpublished data).
Relevance to Human Colon Carcinogenesis
The most striking and unexpected feature of the present results is
first, the magnitude of the effects, which are arguably greater than
those seen for any single oncogene or inactivated tumor suppressor
gene expressed in animals and second, the fact that this
tumorigenic phenotype involves the entire colon in a diffuse
mosaic pattern of changes (Figures 6 and 7) in 100% of the
CEABAC20 mice. CEA, and possibly CEACAM6, over-expres-
sion has been shown to be mutagenic [16,41], leading to the rapid
outgrowth of rat L6 tumors with a dramatically reduced latent
period, reduced even more than that observed with the expression
of a combination of v-myc and Bcl2 [16]. If random mutations
were required in the CEABAC20 mice, however, the neoplastic
changes observed would be focal, as is the case for all other
published mouse models with tumorigenic genetic alterations. The
present case may bear some resemblance to that of mucin Muc2
deletion in mice [44], in which relatively small non-focal increases
in proliferation and decreases in apoptosis were observed in the
entire gastrointestinal tract; in this case, focal carcinomas appeared
later in life, presumably due to secondary mutations. This is
actually the case for the CEABAC2 and CEABAC10 mice which
showed a marked increase in focal carcinomas after azoxymethane
treatment [41]. In the CEABAC20 mice, on the other hand, the
expression level of CEA and CEACAM6 is high enough to drive
the abnormal growth of colonic crypts demonstrated by the
extreme cellular changes within a given crypt. This abnormal and
uncontrolled growth pattern leads to a complete disruption of
normal tissue architecture and a large increase in crypt length. In
fact these primary changes are so dramatic in the CEABAC20
mice that any focal carcinomas would likely have little selective
growth advantage and, in any case, the animals tend to die from
digestive complications before about 6 months of age, thus not
Figure 5. Differentiation block in CEABAC mouse colonic epithelium at 3 weeks of age. A) Mucin staining of colonic crypts of WT, CEABAC2,
CEABAC10, and CEABAC20 mice shows a progressively decreasing number of visible purplish-colored differentiated goblet cells (indicated by an
arrow in the WT colonic crypt) correlated with increasing CEABAC transgene copy number. Lengthening of crypts, poor cryptal alignment, increase of
peri-cryptal stroma, absence of bluish cytoplasm, abundance of small purplish mucinous vacuoles and elongation of nuclei are noted in CEABAC20
mice, indicating hyperplastic changes. Magnification: 4006. Staining: AB/PAS/MG. B) Number of normal-size goblet cells per crypt plotted against
transgene copy-number; each data point is significantly different from the others (P,0.0001). 35%, 67% and 85% (95% after considering the 3-fold
increase in crypt length) reductions relative to WT mice (i.e. 0 transgene copy) are obtained for CEABAC2, CEABAC10 and CEABAC20 mice,
respectively. Error bars represent standard errors of the mean (N=9). WT denotes wild-type littermate.
doi:10.1371/journal.pone.0001353.g005
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is in fact focal, we suggest that, unlike the situation here where every
cell has multiple copies of CEA and CEACAM6 genes, their over-
expression itself in the adult human colon could occur by focal up-
regulation inexpression as observed inthecarcinogen-inducedcolon
tumors in CEABAC2 and CEABAC10 mice [41]. We therefore
propose that the increase in proliferation and inhibition of
differentiation and anoikis together with the disruption of tissue
architecture, induced by CEA/CEACAM6 over-expression in
colonocytes, puts them in a state that is more susceptible to effects
of other oncogenic lesions, thus representing a significant contribu-
tion to malignant transformation [16]. Note that this model does not
require structural mutations in CEA or CEACAM6 themselves and,
in fact, such mutations are generally not observed in cDNAs derived
from human tumors over-expressing these molecules [1].
Another interesting feature of these tumors was their resem-
blance to mixed hyperplastic polyps, serrated polyps and serrated
adenomas in human patients, which are subtypes of pre-cancerous
lesions [45,46] that show increased expression of CEA [47,48]. In
contrast to conventional adenomas in which perturbation of the
Wnt-signaling pathway is commonly believed as the initiating
event [49,50], this serration is a consequence of alteration in cell
proliferation and apoptosis leading to inactivation of DNA repair
genes by promoter methylation and secondary mutations that
cause tumor progression [46]. Based on the proliferative and anti-
apoptotic effects of CEA/CEACAM6 shown in the CEABAC
mice, it is thus possible that this could represent the first animal
model for this type of human colorectal neoplasia.
However, the non-focal concomitant dysplasia observed in the
CEABAC20 mice requires comment. The traditional view is that
hyperplasia is a dead-end state that does not progress to dysplasia.
Although the serrated pathway allows such a transition, only a
small proportion of hyperplastic lesions transform to dysplastic
serrated adenomas after acquiring other gene mutations, such as
hMLH1 or MGMT [46]. The rather frequent non-focal transition
to colonic tissue with features of dysplasia observed in CEABAC20
mice suggests that over-expression of CEA and/or CEACAM6 to
a critical threshold level alone is sufficient to initiate the
transformation of a normal epithelium to a state of dysplasia. It
thus appears that homotypic adhesion molecules with their self-
binding external domains can effect this by clustering without
the need for mutations, either in themselves or in other elements.
Secondary mutations [whose incidence is stimulated by this
state [16]], however, would be required to ensure rigorous
heritability.
Significance for Human Cancer
If these results can be extrapolated to human colorectal cancer, in
which up-regulation of CEA and CEACAM6 occurs as an early
event in adult colonic epithelium [4,8,51], the magnitude of the
tumorigenic effects observed here would imply a very significant
contribution to the malignant phenotype. Thus, clinically, cancer
treatments should aim to reduce their levels and should not further
up-regulate them to enhance tumor targeting. Perhaps more
importantly, strategies designed to reverse their biological effects
rather than to use them as inert targets should be considered. In
fact, reduction of their expression has been shown to reverse some
tumor phenotypes [13,14,52] and to restore sensitivity to
chemotherapeutic agents [53], as have declustering agents [18].
Figure 6. Massive colonic tumors in 3 month-old CEABAC20 mice. A) Cross sections of colon; note the much larger size of the CEABAC20 vs WT
colons. B) Dramatic increase of colon mass and absence of fecal pellets in CEABAC20 over the entire colon. C) Colonic crypts; note the dramatic
lengthening of intensely stained crypts in CEABAC20. Magnification: 406(A), 1006(C). Staining: hematoxylin (A, C).
doi:10.1371/journal.pone.0001353.g006
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MATERIALS AND METHODS
Animals
CEABAC transgenic mice (CEABAC2 and CEABAC10 lines,
bearing 2 and 10 copies of the CEABAC transgene, respectively)
were produced and maintained on the FVB strain background.
Genotypes of mice were determined by PCR as described elsewhere
[30]. CEABAC20 mice (bearing 20 copies of the CEABAC
transgene) were produced from mating two CEABAC10 mice.
Homozygous transgenic mice were identified by fluorescence in situ
hybridization of the CEABAC in splenocytes (see below).
Antibodies
Rabbit polyclonal antibodies (Ab) used were: anti-CEA Ab
(RbaCEA) which recognizes all human CEACAM family members;
anti-integrin a5 Ab (H-104), anti-integrin b1A b( M - 1 0 6 )a n da n t i -
PARP Ab (H-250) which detects the C-terminus of PARP-1 and
PARP-2 (Santa Cruz Biotechnology Inc., Santa Cruz, CA); anti-
FAK Ab (Upstate Cell Signaling, Charlottesville, VA); anti-Akt Ab
which detects the total level of Akt1, Akt2 and Akt3, anti-Phospho-
Akt(Ser473)AbwhichdetectsAkt1onlywhenphosphorylatedatthe
Ser473 residue and also Akt2 and Akt3 when phosphorylated at the
corresponding residues, anti-caspase-3 Ab which detects full length
caspase-3and thelargefragment ofcleaved caspase-3 (CellSignaling
Technology Inc., Beverley, MA). Mouse monoclonal antibodies
(mAb) used were: anti-CEA mAb (J22 and A20) which recognize the
internal domains of CEA and CEACAM6 and the N-terminal
domain of CEA, respectively [54]; anti-CEA mAb (T84.66) which
recognizes only CEA (ATCC, Manassas, VA); anti-CEACAM6
mAb (9A6) which recognizes only CEACAM6 [4]; anti-ILK mAb
(BD Biosciences, Mississauga, Canada); and anti-PCNA mAb
(PC10) (DAKO Diagnostics Canada Inc., Mississauga, Canada).
Hamster monoclonal antibodies used are: anti-integrin a5m A b
(HMa5-1) (BD Biosciences) and anti-integrin a2 mAb (HMalpha2)
(Chemicon International Inc., Temecula, CA).
Fluorescence In Situ Hybridization and TUNEL Assay
For fluorescence in situ hybridization (FISH), freshly isolated
splenocytes were treated as previously described [55]; DIG-labeled
CEA cDNA probes were generated using the High Prime DNA
Labeling Kit (Roche Diagnostics Inc., Laval, Canada), and
Figure 7. Histopathological findings in CEABAC20 tumors including serrated adenomatous and dysplastic morphology. A) Longitudinal section
of normal colonic crypts. B) Longitudinal sections of serrated colonic crypts showing upper third of the elongated crypts (left panel), sawtooth like in-
folding at the mid-crypt (middle panel) and marked branching at the crypt base (right panel). C) Cross-section of a hyperplastic crypt (red arrow)
showing numerous small mucinous vacuoles. D) Longitudinal section (left panel) and cross-section (right panel) of dysplastic crypts showing
elongated nuclei and nuclear stratification (red arrow). There is also evidence of myofibroblastic (spindle cell) proliferation in the lamina propria in C
and D. Magnification: 4006. Staining: hematoxylin and eosin.
doi:10.1371/journal.pone.0001353.g007
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er Set for DIG Detection (Roche Diagnostics Inc.). The terminal
deoxynucleotidyl transferase (TdT)-mediated dUTP Nick-End-
Labeling (TUNEL) assay was used to detect apoptotic cells
according to the protocol provided by the APOAlert
TM DNA
Fragmentation Assay Kit (BD Biosciences). Fluorescent cells were
visualized using a fluorescent light microscope.
Isolation of Mouse Colonic Epithelial Cells
Colonic epithelial cells were isolated from mice using a protocol
modified from one previously described for human samples [56].
Briefly, 6 intact mouse colons were flipped inside-out and
incubated for 30 minutes in a 1.3 mM DTT/PBS solution at
room temperature and then 10 minutes in a 1.5 mM EDTA/PBS
solution at 37uC. Intact colonic crypts were separated from the
underlying layers by vigorous shaking, collected using a 40-mm
nylon cell strainer (BD Biosciences) and treated with dispase
(1.2 mg/ml) for 10 minutes to give a single-cell suspension.
Detection of cell surface levels of CEA, CEACAM6
and integrins
Cell surface levels of CEA, CEACAM6 and integrins on purified
colonic epithelial cells were determined by fluorescence-activated
cell sorting (FACS) analysis, as described elsewhere [41], using
T84.66, 9A6, HMa5-1, and HMalpha2 Abs.
Anoikis Assay for Purified Colonic Epithelial Cells
Single cell suspensions of purified colonocytes were incubated in
suspension in serum-free DMEM medium for 1 or 3 hours at
Figure 8. Inhibition of apoptosis/anoikis in CEABAC mice. A) TUNEL assays on formaldehyde-fixed frozen sections of WT and CEABAC20 colons.
Cyan (red arrow): apoptotic nuclei; Blue (yellow arrow): non-apoptotic nuclei. Note the presence of non-apoptotic anchorless cells, which are CEA/
CEACAM6-positive (data not shown), in the crypt lumens of CEABAC20 colons (yellow arrow). Magnification: 4006. Staining: DAPI. B) Immunoblots of
colon protein extracts for PARP show reduced cleavage product of PARP (DPARP) indicating an overall reduction of apoptosis in CEABAC20 mouse
colons. C) TUNEL assays on purified colonocytes show a marked inhibition of anoikis of CEABAC colonocytes compared to WT colonocytes after
3 hours in single cell suspension. Negative control (freshly purified WT colonocytes) is completely TUNEL negative. Positive control (freshly purified
WT colonocytes treated with DNAseI) is TUNEL positive. D) Apoptotic indices estimated from 3 independent experiments shown in C. E) Immunoblots
of colonocyte lysates from anoikis experiment for caspase-3 show a baseline cleavage of caspase-3 (DCaspase3) at time 0 (freshly purified
colonocytes) and a marked reduction of caspase-3 cleavage at time 1 hr (after 1 hour in single cell suspensions) for CEABAC mice, indicating
inhibition of anoikis in the CEABAC colonocytes.
doi:10.1371/journal.pone.0001353.g008
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analysis of caspase-3 cleavage after 1 hour (see below) and by the
TUNEL assay after 3 hours (see above). Baseline apoptosis was
determined immediately after purification. For a positive control
of the TUNEL assay, cells were pre-treated with DNAse I (1 mg/
ml). For a negative control, TdT was omitted in the TUNEL
reaction. Apoptotic index was expressed as a percentage of
apoptotic cells over the total number of cells counted.
Isolation of Membrane Rafts
Membrane rafts were isolated from 5–10 6 10
6 purified colonic
epithelial cells by isopycnic sucrose density gradient centrifugation;
membrane raft-containing fractions were identified by the
presence of GM1 using dot-blots, as described previously [21].
Immunoblot analysis
Crude colonic tissue extracts were obtained by scraping colonic
mucosa away from the underlying layers, homogenizing with PBS
on ice and lysing with SDS lysis buffer (100 mM Tris pH 8, 10%
glycerol, 2% SDS). Colonic epithelial extracts were obtained by
lysis of purified colonic epithelial cells (see above for isolation) in
RIPA lysis buffer (20 mM Tris-HCl pH 8, 140 mM NaCl, 2 mM
EDTA pH 8, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 100 mg/
ml PMSF, 1 mM NaVO3, 10 mM NaF). Proteins from crude
colonic tissue extracts, purified colonic epithelial extracts or
sucrose gradient fractions were detected by immunoblot analyses,
as described elsewhere [21].
Histological analysis and immunohistochemistry
For cryosection, freshly collected tissues were fixed with 4%
paraformaldehyde and processed as described elsewhere [30]. For
paraffin-embedded sections, freshly excised tissues were fixed in
Glyo-Fixx (20% ethanol, 5% glyoxal, 1% propanol and 1%
methanol) for 48 hours at room temperature and processed for
embedding in paraffin blocks for sectioning. For general
histopathology, frozen sections were stained with hematoxylin
and paraffin-embedded sections were stained with hematoxylin
and eosin [57]. To assess colonocyte differentiation, frozen
sections were stained by the ‘‘alcian blue-periodic acid Schiff’’
method to detect mucin, followed by methyl green staining to
detect nuclei (AB-PAS-MG) [57]. For immunohistochemistry,
frozen sections were probed with RbaCEA antibodies as described
elsewhere [30]. Actively proliferating cells were detected using
HRP-conjugated mouse monoclonal anti-PCNA antibody.
Differentiation and Proliferation Analyses
For differentiation and proliferation analyses, animals were
sacrificed at exactly postnatal day 21 to minimize growth
variation. Percent crypt fission was scored as the percentage of
forked dividing crypts over the total number of crypt bases for
about 100 crypts. Proliferation index was scored as the number of
PCNA-positive nuclei divided by total number of nuclei in about
10 individual crypts. The level of differentiation was scored as the
number of large goblet cells (mucin vacuole of more than 10 mm)
over the total number of crypt bases for about 100 crypts.
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